Barriers to rheumatologists adopting a treat-to-target approach in psoriatric arthritis (PsA), include lack of time, a feeling it is too difficult and lack of protocols and training, UK researchers have found. Despite EULAR guidance from 2015 advising a treat-to-target approach in PsA, it has not been widely implemented for reasons that need to be better ...
Treat-to-target still in ‘too hard basket’ for PsA
By Emma Wilkinson
15 Jun 2020